Carbohydrate-Based Macromolecular Biomaterials DOI
Lu Su, Yingle Feng, Kongchang Wei

et al.

Chemical Reviews, Journal Year: 2021, Volume and Issue: 121(18), P. 10950 - 11029

Published: Aug. 2, 2021

Carbohydrates are the most abundant and one of important biomacromolecules in Nature. Except for energy-related compounds, carbohydrates can be roughly divided into two categories: as matter information. As matter, abundantly present extracellular matrix animals cell walls various plants, bacteria, fungi, etc., serving scaffolds. Some commonly found polysaccharides featured biocompatible materials with controllable rigidity functionality, forming polymeric biomaterials which widely used drug delivery, tissue engineering, etc. information, usually referred to glycans from glycoproteins, glycolipids, proteoglycans, bind proteins or other carbohydrates, thereby meditating cell–cell cell–matrix interactions. These could simplified synthetic glycopolymers, afforded through polymerization, multistep synthesis, a semisynthetic strategy. The information role demonstrated not only targeting reagents but also immune antigens adjuvants. latter included this review they always macromolecular formulation. In review, we intend provide relatively comprehensive summary carbohydrate-based since 2010 while emphasizing fundamental understanding guide rational design biomaterials. Carbohydrate-based macromolecules on basis their resources chemical structures will discussed, including naturally occurring polysaccharides, derived glycopolymers/glycodendrimers, supramolecular glycolipids/glycoproteins. Multiscale structure–function relationships several major application areas, delivery systems, immunology, detailed. We hope valuable development build bridge between promote new biomaterial near future.

Language: Английский

Evolutionary classification of CRISPR–Cas systems: a burst of class 2 and derived variants DOI
Kira S. Makarova, Yuri I. Wolf, Jaime Iranzo

et al.

Nature Reviews Microbiology, Journal Year: 2019, Volume and Issue: 18(2), P. 67 - 83

Published: Dec. 19, 2019

Language: Английский

Citations

1993

Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors DOI
Andrew V. Anzalone, Luke W. Koblan, David R. Liu

et al.

Nature Biotechnology, Journal Year: 2020, Volume and Issue: 38(7), P. 824 - 844

Published: June 22, 2020

Language: Английский

Citations

1827

Human organoids: model systems for human biology and medicine DOI Open Access
Jihoon Kim, Bon‐Kyoung Koo, Juergen A. Knoblich

et al.

Nature Reviews Molecular Cell Biology, Journal Year: 2020, Volume and Issue: 21(10), P. 571 - 584

Published: July 7, 2020

Language: Английский

Citations

1626

The promise and challenge of therapeutic genome editing DOI
Jennifer A. Doudna

Nature, Journal Year: 2020, Volume and Issue: 578(7794), P. 229 - 236

Published: Feb. 12, 2020

Language: Английский

Citations

915

RNA-based therapeutics: an overview and prospectus DOI Creative Commons
Yiran Zhu, Liyuan Zhu, Xian Wang

et al.

Cell Death and Disease, Journal Year: 2022, Volume and Issue: 13(7)

Published: July 23, 2022

Abstract The growing understanding of RNA functions and their crucial roles in diseases promotes the application various RNAs to selectively function on hitherto “undruggable” proteins, transcripts genes, thus potentially broadening therapeutic targets. Several RNA-based medications have been approved for clinical use, while others are still under investigation or preclinical trials. Various techniques explored promote intracellular trafficking metabolic stability, despite significant challenges developing therapeutics. In this review, mechanisms action, challenges, solutions, therapeutics comprehensively summarized.

Language: Английский

Citations

392

Knee Osteoarthritis: A Review of Pathogenesis and State-Of-The-Art Non-Operative Therapeutic Considerations DOI Open Access
Dragan Primorac, Vilim Molnar,

Eduard Rod

et al.

Genes, Journal Year: 2020, Volume and Issue: 11(8), P. 854 - 854

Published: July 26, 2020

Being the most common musculoskeletal progressive condition, osteoarthritis is an interesting target for research. It estimated that prevalence of knee (OA) among adults 60 years age or older approximately 10% in men and 13% women, making OA one leading causes disability elderly population. Today, we know not a disease characterized by loss cartilage due to mechanical loading only, but condition affects all tissues joint, causing detectable changes tissue architecture, its metabolism function. All these are mediated complex yet fully researched interplay proinflammatory anti-inflammatory cytokines, chemokines, growth factors adipokines, which can be measured serum, synovium histological samples, potentially serving as biomarkers stage progression. Another key aspect progression epigenome regulates genetic expression through DNA methylation, histone modifications, mRNA interference. A lot work has been put into developing non-surgical treatment options slow down natural course postpone, maybe even replace extensive surgeries such total arthroplasty. At moment, biological treatments platelet-rich plasma, bone marrow mesenchymal stem cells autologous microfragmented adipose containing stromal vascular fraction ordinarily used. Furthermore, latter two mentioned cell-based seem only methods so far increase quality patients. Yet, future, gene therapy could become option orthopedic In following review, summarized latest important research basic sciences, pathogenesis, non-operative treatment.

Language: Английский

Citations

376

CRISPR technologies for precise epigenome editing DOI
Muneaki Nakamura, Yuchen Gao, Antonia A. Dominguez

et al.

Nature Cell Biology, Journal Year: 2021, Volume and Issue: 23(1), P. 11 - 22

Published: Jan. 1, 2021

Language: Английский

Citations

357

Engineering microrobots for targeted cancer therapies from a medical perspective DOI Creative Commons
Christine K. Schmidt, Mariana Medina‐Sánchez, Richard J. Edmondson

et al.

Nature Communications, Journal Year: 2020, Volume and Issue: 11(1)

Published: Nov. 5, 2020

Abstract Systemic chemotherapy remains the backbone of many cancer treatments. Due to its untargeted nature and severe side effects it can cause, numerous nanomedicine approaches have been developed overcome these issues. However, targeted delivery therapeutics challenging. Engineering microrobots is increasingly receiving attention in this regard. Their functionalities, particularly their motility, allow penetrate tissues reach cancers more efficiently. Here, we highlight how different microrobots, ranging from tailor-made motile bacteria tiny bubble-propelled microengines hybrid spermbots, be engineered integrate sophisticated features optimised for precision-targeting a wide range cancers. Towards this, importance integrating clinicians, public patients early on development novel technologies.

Language: Английский

Citations

342

CRISPR/Cas9 therapeutics: progress and prospects DOI Creative Commons
Tianxiang Li, Yanyan Yang, Hongzhao Qi

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2023, Volume and Issue: 8(1)

Published: Jan. 16, 2023

Abstract Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) gene-editing technology is the ideal tool of future for treating diseases by permanently correcting deleterious base mutations or disrupting disease-causing genes with great precision and efficiency. A variety efficient Cas9 variants derivatives have been developed to cope complex genomic changes that occur during diseases. However, strategies effectively deliver CRISPR system diseased cells in vivo are currently lacking, nonviral vectors target recognition functions may be focus research. Pathological physiological resulting from disease onset expected serve as identifying factors targeted delivery targets gene editing. Diseases both varied complex, choice appropriate methods different important. Meanwhile, there still many potential challenges identified when targeting CRISPR/Cas9 treatment. This paper reviews current developments three aspects, namely, type, vector, characteristics. Additionally, this summarizes successful examples clinical trials finally describes possible problems associated applications.

Language: Английский

Citations

337

Prime editing for precise and highly versatile genome manipulation DOI
Peter J. Chen, David R. Liu

Nature Reviews Genetics, Journal Year: 2022, Volume and Issue: 24(3), P. 161 - 177

Published: Nov. 7, 2022

Language: Английский

Citations

333